Page last updated: 2024-10-20

picolinic acid and Osteoporosis, Postmenopausal

picolinic acid has been researched along with Osteoporosis, Postmenopausal in 1 studies

picolinic acid: iron-chelating agent that inhibits DNA synthesis; may interfere with iron-dependent production of stable free organic radical which is essential for ribonucleotide reductase formation of deoxyribonucleotides; RN given refers to parent cpd; structure in Merck Index, 9th ed, #7206
picolinic acid : A pyridinemonocarboxylic acid in which the carboxy group is located at position 2. It is an intermediate in the metabolism of tryptophan.

Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McCarty, MF1

Other Studies

1 other study available for picolinic acid and Osteoporosis, Postmenopausal

ArticleYear
Anabolic effects of insulin on bone suggest a role for chromium picolinate in preservation of bone density.
    Medical hypotheses, 1995, Volume: 45, Issue:3

    Topics: Animals; Bone Density; Bone Resorption; Calcium; Collagen; Dehydroepiandrosterone; Dehydroepiandrost

1995